Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 7/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | ACACB | O00763 | 1/20 | 0.33 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12646354 | 0.84 | BCHE (0.33) | BCHE | |
| SCHEMBL16002524 | 0.83 | ALDH1A1 (0.39) | BCHEACACBPOLB | |
| SCHEMBL21511221 | 0.83 | ALDH1A1 (0.39) | BCHEACACBPOLB | |
| SCHEMBL17518705 | 0.81 | BCHE (0.33) | BCHEACACB | |
| SCHEMBL20727181 | 0.81 | BCHE (0.33) | BCHEACACB | |
| SCHEMBL26012764 | 0.79 | BCHE (0.41) | BCHESLC18A3 | |
| SCHEMBL7150802 | 0.78 | BCHE (0.54) | BCHECHRM2CHRM1MEN1CYP2D6 | |
| SCHEMBL12199932 | 0.78 | BCHE (0.54) | BCHECHRM2CHRM1MEN1CYP2D6 | |
| SCHEMBL7152562 | 0.78 | BCHE (0.54) | BCHECHRM2CHRM1MEN1CYP2D6 | |
| SCHEMBL7276665 | 0.78 | BCHE (0.54) | BCHECHRM2CHRM1MEN1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160229863-A1 | ISOSORBIDE-BASED POLYMETHACRYLATES | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2016-08-11 | — | — | US | disclosed |
| US-7671164-B2 | Aliphatic polycarbonates, methods of making, and articles formed therefrom | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-03-02 | — | — | US | disclosed |
| US-20090105443-A1 | ALIPHATIC POLYCARBONATES, METHODS OF MAKING, AND ARTICLES FORMED THEREFROM | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160229863-A1 | ISOSORBIDE-BASED POLYMETHACRYLATES | AKR1C4, AKR1C3, AKR1C2 | BCHE 1284/4885CHRM2 1382/4885CHRM1 1330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.